About

ABOUT US

About Us

Treatment for Overactive Bladder

URO-1 develops breakthrough products for office procedures in Urology and Urogynecology, which improve clinical outcomes, enhance patient experience and increase procedure efficiency.

These products increase the diagnostic accuracy of prostate biopsy, reduce workload and improve workflow in the clinic and the pathology lab.

Meet the team

Management Team

Ted Belleza

President & CEO

Read Bio

Jack Snoke

COO & CTO

Read Bio

John J. Smith MD, FACS

CMO

Read Bio

Philip Allred

VP R&D

Read Bio

Chloe Chan

Consulting CFO

Read Bio

READ ABOUT

Our Story

URO-1 creates breakthrough solutions for office procedures in urology which improve outcome, patient experience and procedure efficiency.

URO-1 is a portfolio company of the North Carolina Biotechnology Center.
www.ncbiotech.org

Meet Our Team

Milestones

UPCOMING EVENTS

Our Goal

To improve the current standards of care in the diagnosis and treatment of urologic disorders by creating and optimizing procedure specific instruments.

Site Links

Products

© 2021 URO-1 Inc. URO-1, Repris, Re4m, Rely, SUREcore, coreCARE and their respective logos are trademarks of URO-1 Inc. All other trademarks are the property of their respective holders. Repris Bladder Injection System: US patents 10,286,159; 10,456,164; 10,463,797; 10,953,159. China patent ZL 201890000398.0 SUREcore and coreCARE: Patents Pending
PN60004 Rev C

About

ABOUT US

Treatment for Overactive Bladder

Management Team

Meet Our Team

Milestones

UPCOMING EVENTS

© Copyright 2023 by Weblify & Webtec

Ted Belleza

President & CEO

Jack Snoke

COO & CTO

John J. Smith MD

FACS, CMO

Philip Allred

VP R&D

Chloe Chan

Consulting CFO